Cervical cancer screening and treatment are neglected in low- and middle-income countries

August 13, 2013, Public Library of Science

While there have been substantial improvements in mortality rates and an increase in access to reproductive health interventions in low- and middle-income countries (LMICs), the global health community is neglecting prevention, screening, and treatment for cervical cancer in LMICs. These are the conclusions of a new article in PLOS Medicine this week by Ruby Singhrao and colleagues from the University of California San Francisco, San Francisco.

Using a framework including equity and socio-economic, gender, public health, and health services dimensions, the authors propose four arguments for why screening and treatment should be included as part of the "post-2015 development agenda," for improving reproductive and maternal health outcomes. They argue that the burden of cervical cancer falls on women of reproductive age and that cervical cancer is associated with reduced reproductive capacity. Furthermore, cervical cancer screening and treatment can be integrated into other health services and recent evidence demonstrates that HPV vaccination can protect girls from pre-.

"For cervical cancer, we fortunately now have a wide range of feasible, affordable, and effective prevention options, which make dramatic global reductions in cervical cancer incidence a realistic goal in our lifetime", conclude the authors.

Explore further: Study suggests STD clinics could reduce obstacles to much needed cervical cancer screenings

More information: Singhrao R, Huchko M, Yamey G (2013) Reproductive and Maternal Health in the Post 2015 Era: Cervical Cancer Must Be a Priority. PLoS Med 10(8): e1001499. DOI: 10.1371/journal.pmed.1001499

Related Stories

Study suggests STD clinics could reduce obstacles to much needed cervical cancer screenings

July 16, 2013
A new study found that STD clinics could provide important access to cervical cancer screenings for women who traditionally have trouble receiving these screenings because of lack of insurance or other obstacles.

Too many Pap tests

July 26, 2013
Most Australian women are currently having more Pap smears than their health requires, according to new research led by a University of New South Wales academic.

HPV testing could cut cervical cancers by a third

June 14, 2013
(Medical Xpress)—Testing women for the human papillomavirus (HPV) first, instead of using the traditional cervical screening test to detect abnormal cells in the cervix, could prevent around 600 cases of cervical cancer ...

Lack of clarity about HPV vaccine and the need for cervical cancer screening

July 7, 2011
The research will be presented today at the Annual Scientific Meeting of the Society of Academic Primary Care, hosted this year by the Academic Unit of Primary Health Care, University of Bristol.

Self-collection of samples for HPV testing shows promise in detection of cervical cancer in Kenya

May 1, 2013
In Kenya, women face a cervical cancer mortality rate that is approximately 10 times as high as in the United States. A study by researchers at the University of North Carolina at Chapel Hill suggests that training women ...

New study explores providers' perceptions of parental concerns about HPV vaccination

May 14, 2013
A new Boston University School of Medicine (BUSM) study has found that low-income and minority parents may be more receptive to vaccinating their daughters against Human Papillomavirus (HPV), while white, middle-class parents ...

Recommended for you

Eating foods with low nutritional quality ratings linked to cancer risk in large European cohort

September 18, 2018
The consumption of foods with higher scores on the British Food Standards Agency nutrient profiling system (FSAm-NPS), reflecting a lower nutritional quality, is associated with an increased risk of developing cancer, according ...

CRISPR screen reveals new targets in more than half of all squamous cell carcinomas

September 18, 2018
A little p63 goes a long way in embryonic development—and flaws in p63 can result in birth defects like cleft palette, fused fingers or even missing limbs. But once this early work is done, p63 goes silent, sitting quietly ...

Enlarged genotype-phenotype correlation for a three-base pair deletion in neurofibromatosis type 1

September 18, 2018
International collaborative research led by Ludwine Messiaen, Ph.D., shows that while a three-base pair, in-frame deletion called p.Met992del in the NF1 gene has a mild phenotype for people with the genetic disorder neurofibromatosis ...

Artificial intelligence can determine lung cancer type

September 17, 2018
A new computer program can analyze images of patients' lung tumors, specify cancer types, and even identify altered genes driving abnormal cell growth, a new study shows.

Researchers develop mechanism for characterizing function of rare tumor cells

September 17, 2018
Scientists have long known that circulating tumor cells, rare cancer cells that are released into the bloodstream, have the potential to provide vital information about a person's specific cancer. But until now, they have ...

Nanoparticle therapeutic restores function of tumor suppressor in prostate cancer

September 17, 2018
Think of it as a cancer therapy zag instead of a zig. While many groups are developing cancer therapies to target proteins and pathways that are highly active in cancer cells, a team of investigators from Brigham and Women's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.